NF-κB and HIF crosstalk in immune responses

FEBS Journal

Volumn 283, Issue 3, 2016, Pages 413-424

  D'Ignazio, Laura ^a   Bandarra, Daniel ^a   Rocha, Sonia ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

B cells; HIF; Hypoxia; IKK; Immune response; Inflammation; Macrophages; Neutrophils; NF B; T cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE 6; EARLY GROWTH RESPONSE FACTOR 1; GLUCOSE TRANSPORTER 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BCL XL; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; HYPOXIA INDUCIBLE FACTOR 1;

ANGIOGENESIS; APOPTOSIS; ASTHMA; AUTOPHAGY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DENDRITIC CELL; DNA BINDING; GLYCOLYSIS; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; HUMAN; HYPOXIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; LIVER CELL CARCINOMA; MACROPHAGE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NEOPLASM; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; IMMUNITY; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNITY; MACROPHAGES; NEUTROPHILS; NF-KAPPA B; T-LYMPHOCYTE SUBSETS;

EID: 84960402826     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13578     Document Type: Review

References (90)

1. Perkins ND (2012) The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 12, 121-132.
2. Rius J, Guma M, Schachtrup C., Akassoglou K, Zinkernagel AS, Nizet V, Johnson R.S., Haddad GG & Karin M (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453, 807-811.
3. Simmonds RE & Foxwell BM (2008) Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47, 584-590.
4. Sen R & Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.
5. Courtois G & Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25, 6831-6843.
6. Baeuerle PA & Baltimore D (1996) NF-kappa B: ten years after. Cell 87, 13-20.
7. Oeckinghaus A & Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1, a000034.
8. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
9. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8, 49-62.
10. Perkins ND & Gilmore TD (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 13, 759-772.
11. Baeuerle PA & Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12, 141-179.
12. Hatada EN, Krappmann D & Scheidereit C (2000) NF-kappaB and the innate immune response. Curr Opin Immunol 12, 52-58.
13. Hayden MS, West AP & Ghosh S (2006) NF-kappaB and the immune response. Oncogene 25, 6758-6780.
14. Medzhitov R & Janeway CA Jr (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9, 4-9.
15. Droebner K, Klein B, Paxian S., Schmid R, Stitz L & Planz O (2010) The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection. Viral Immunol 23, 295-308.
16. van de Laar L, van den Bosch A, van der Kooij SW, Janssen HL, Coffer PJ, van Kooten C & Woltman AM (2010) A nonredundant role for canonical NF-kappaB in human myeloid dendritic cell development and function. J Immunol 185, 7252-7261.
17. Liou HC, Sha WC, Scott ML & Baltimore D (1994) Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 14, 5349-5359.
18. Wu L, D'Amico A, Winkel KD, Suter M, Lo D & Shortman K (1998) RelB is essential for the development of myeloid-related CD8alpha-dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 9, 839-847.
19. Zhou J, Zhang J, Lichtenheld MG & Meadows GG (2002) A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling. J Immunol 169, 1319-1325.
20. Gerondakis S, Fulford TS, Messina NL & Grumont RJ (2014) NF-kappaB control of T cell development. Nat Immunol 15, 15-25.
21. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
22. Moniz S, Biddlestone J & Rocha S (2014) Grow(2): the HIF system, energy homeostasis and the cell cycle. Histol Histopathol 29, 589-600.
23. Fandrey J, Gorr TA & Gassmann M (2006) Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 71, 642-651.
24. Peet D & Linke S (2006) Regulation of HIF: asparaginyl hydroxylation. Novartis Found Symp 272, 37-49; discussion 49-53, 131-40.
25. Schaffer K & Taylor CT (2015) The impact of hypoxia on bacterial infection. FEBS J 282, 2260-2266.
26. Scott C, Bonner J, Min D., Boughton P, Stokes R, Cha K.M., Walters SN, Maslowski K, Sierro F, Grey ST et al. (2014) Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing. Am J Physiol Cell Physiol 307, C349-C357.
27. Thompson AA, Elks PM, Marriott H.M., Eamsamarng S., Higgins KR, Lewis A, Williams L, Parmar S., Shaw G, McGrath EE et al. (2014) Hypoxia-inducible factor 2alpha regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123, 366-376.
28. Nakamura H, Makino Y, Okamoto K., Poellinger L, Ohnuma K, Morimoto C & Tanaka H (2005) TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J Immunol 174, 7592-7599.
29. Dang EV, Barbi J, Yang H.Y., Jinasena D., Yu H, Zheng Y, Bordman Z., Fu J, Kim Y, Yen HR et al. (2011) Control of T(H)17/T(reg) balance by hypoxiainducible factor 1. Cell 146, 772-784.
30. Biddlestone J, Bandarra D & Rocha S (2015) The role of hypoxia in inflammatory disease (review). Int J Mol Med 35, 859-869.
31. Bandarra D & Rocha S (2013) Tale of two transcription factors: NF-κB and HIF crosstalk. OA Mol Cell Biol 1, 1-7.
32. Koong AC, Chen EY & Giaccia AJ (1994) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 54, 1425-1430.
33. Culver C, Sundqvist A, Mudie S., Melvin A, Xirodimas D & Rocha S (2010) Mechanism of hypoxia-induced NF-kappaB. Mol Cell Biol 30, 4901-4921.
34. Bandarra D, Biddlestone J, Mudie S., Muller HA & Rocha S (2015) HIF-1alpha restricts NF-kappaB-dependent gene expression to control innate immunity signals. Dis Model Mech 8, 169-181.
35. van Uden P., Kenneth NS & Rocha S (2008) Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412, 477-484.
36. van Uden P., Kenneth NS, Webster R, Muller H.A., Mudie S & Rocha S (2011) Evolutionary conserved regulation of HIF-1beta by NF-kappaB. PLoS Genet 7, e1001285.
37. Xue X, Ramakrishnan S, Anderson E., Taylor M, Zimmermann EM, Spence J.R., Huang S., Greenson JK & Shah YM (2013) Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology 145, 831-841.
38. Karhausen J, Furuta GT, Tomaszewski J.E., Johnson RS, Colgan SP & Haase VH (2004) Epithelial hypoxiainducible factor-1 is protective in murine experimental colitis. J Clin Investig 114, 1098-1106.
39. Wright CW & Duckett CS (2009) The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription. Science 323, 251-255.
40. Bracken CP, Whitelaw ML & Peet DJ (2005) Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. J Biol Chem 280, 14240-14251.
41. Cummins EP, Berra E, Comerford K.M., Ginouves A., Fitzgerald KT, Seeballuck F, Godson C, Nielsen J.E., Moynagh P., Pouyssegur J et al. (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103, 18154-18159.
42. Peyssonnaux C, Cejudo-Martin P, Doedens A., Zinkernagel AS, Johnson RS & Nizet V (2007) Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178, 7516-7519.
43. Walmsley SR, Print C, Farahi N., Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A., Condliffe AM, Cowburn AS, Johnson N et al. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201, 105-115.
44. Hirota K (2015) Involvement of hypoxia-inducible factors in the dysregulation of oxygen homeostasis in sepsis. Cardiovas Hematol Dis Drug Targets 15, 29-40.
45. Campbell EL, Bruyninckx WJ, Kelly C.J., Glover LE, McNamee EN, Bowers BE, Bayless A.J., Scully M., Saeedi BJ, Golden-Mason L et al. (2014) Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66-77.
46. Nizet V & Johnson RS (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9, 609-617.
47. Peyssonnaux C, Datta V, Cramer T., Doedens A, Theodorakis EA, Gallo R.L., Hurtado-Ziola N, Nizet V & Johnson RS (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Investig 115, 1806-1815.
48. Imtiyaz HZ, Williams EP, Hickey M.M., Patel SA, Durham AC, Yuan LJ, Hammond R, Gimotty P.A., Keith B & Simon MC (2010) Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Investig 120, 2699-2714.
49. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3, 23-35.
50. Strehl C, Fangradt M, Fearon U., Gaber T, Buttgereit F & Veale DJ (2014) Hypoxia: how does the monocytemacrophage system respond to changes in oxygen availability? J Leukoc Biol 95, 233-241.
51. Murdoch C, Muthana M & Lewis CE (2005) Hypoxia regulates macrophage functions in inflammation. J Immunol 175, 6257-6263.
52. Burke B, Giannoudis A, Corke K.P., Gill D., Wells M, Ziegler-Heitbrock L & Lewis CE (2003) Hypoxiainduced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163, 1233-1243.
53. Cramer T, Yamanishi Y, Clausen B.E., Forster I., Pawlinski R, Mackman N, Haase V.H., Jaenisch R., Corr M, Nizet V et al. (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
54. Fangradt M, Hahne M, Gaber T., Strehl C, Rauch R, Hoff P., Lohning M, Burmester GR & Buttgereit F (2012) Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia. Arthritis Res Ther 14, R181.
55. Bredetean O, Ciochina AD & Mungiu OC (2007) The neutrophil in human pathology. Rev Med Chir Soc Med Nat Iasi 111, 446-453.
56. Walmsley SR, Chilvers ER, Thompson A.A., Vaughan K., Marriott HM, Parker LC, Shaw G, Parmar S., Schneider M, Sabroe I et al. (2011) Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J Clin Investig 121, 1053-1063.
57. Oh H & Ghosh S (2013) NF-kappaB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev 252, 41-51.
58. Phan AT & Goldrath AW (2015) Hypoxia-inducible factors regulate T cell metabolism and function. Mol Immunol doi: 10.1016/j.molimm.2015.08.004 [Epub ahead of print].
59. McNamee EN, Korns Johnson D, Homann D & Clambey ET (2013) Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol Res 55, 58-70.
60. Biju MP, Neumann AK, Bensinger S.J., Johnson RS, Turka LA & Haase VH (2004) Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol 24, 9038-9047.
61. Kurobe H, Urata M, Ueno M., Ueki M, Ono S, Izawa-Ishizawa Y, Fukuhara Y., Lei Y, Ripen AM, Kanbara T et al. (2010) Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling. Arterioscler Thromb Vasc Biol 30, 210-217.
62. Thiel M, Caldwell CC, Kreth S, Kuboki S., Chen P, Smith P, Ohta A., Lentsch AB, Lukashev D & Sitkovsky MV (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2, e853.
63. Cheng J, Montecalvo A & Kane LP (2011) Regulation of NF-kappaB induction by TCR/CD28. Immunol Res 50, 113-117.
64. Clambey ET, McNamee EN, Westrich J.A., Glover LE, Campbell EL, Jedlicka P, de Zoeten EF, Cambier JC, Stenmark KR, Colgan SP et al. (2012) Hypoxiainducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA 109, E2784-E2793.
65. Ben-Shoshan J., Maysel-Auslender S, Mor A., Keren G & George J (2008) Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38, 2412-2418.
66. Isomura I, Palmer S, Grumont R.J., Bunting K., Hoyne G, Wilkinson N, Banerjee A., Proietto A, Gugasyan R, Wu L et al. (2009) c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J Exp Med 206, 3001-3014.
67. Shi LZ, Wang R, Huang G., Vogel P, Neale G, Green DR & Chi H (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208, 1367-1376.
68. Bruzzese L, Fromonot J, By Y., Durand-Gorde JM, Condo J, Kipson N., Guieu R, Fenouillet E & Ruf J (2014) NF-kappaB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A (2A) receptors. Cell Signal 26, 1060-1067.
69. Gasparini C, Celeghini C, Monasta L & Zauli G (2014) NF-kappaB pathways in hematological malignancies. Cell Mol Life Sci 71, 2083-2102.
70. Kojima H, Gu H, Nomura S., Caldwell CC, Kobata T, Carmeliet P, Semenza GL & Sitkovsky MV (2002) Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha deficient chimeric mice. Proc Natl Acad Sci USA 99, 2170-2174.
71. Kojima H, Kobayashi A, Sakurai D., Kanno Y, Hase H, Takahashi R., Totsuka Y, Semenza GL, Sitkovsky MV & Kobata T (2010) Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol 184, 154-163.
72. Qiao Q, Nozaki Y, Sakoe K., Komatsu N & Kirito K (2010) NF-kappaB mediates aberrant activation of HIF-1 in malignant lymphoma. Exp Hematol 38, 1199-1208.
73. Moniz S, Bandarra D, Biddlestone J., Campbell KJ, Komander D, Bremm A & Rocha S (2015) Cezanne regulates E2F1-dependent HIF2alpha expression. J Cell Sci 128, 3082-3093.
74. Gierut A, Perlman H & Pope RM (2010) Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am 36, 271-296.
75. Schuliga M (2015) NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules 5, 1266-1283.
76. Balamurugan K (2015) HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer doi: 10.1002/ijc.29519 [Epub ahead of print].
77. Liu H & Pope RM (2003) The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 3, 317-322.
78. Al-Shukaili AK & Al-Jabri AA (2006) Rheumatoid arthritis, cytokines and hypoxia. What is the link? Saudi Med J 27, 1642-1649.
79. Hermann JA, Hall MA, Maini R.N., Feldmann M & Brennan FM (1998) Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 41, 1388-1397.
80. Salter M, Biggadike K, Matthews J.L., West MR, Haase MV, Farrow SN, Uings IJ & Gray DW (2007) Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 293, L660-L667.
81. Greenwood KK, Proper SP, Saini Y, Bramble L.A., Jackson-Humbles DN, Wagner JG, Harkema JR & LaPres JJ (2012) Neonatal epithelial hypoxia inducible factor-1alpha expression regulates the response of the lung to experimental asthma. Am J Physiol Lung Cell Mol Physiol 302, L455-L462.
82. Hart LA, Krishnan VL, Adcock I.M., Barnes PJ & Chung KF (1998) Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 158, 1585-1592.
83. Caramori G, Romagnoli M, Casolari P., Bellettato C, Casoni G, Boschetto P., Chung KF, Barnes PJ, Adcock IM, Ciaccia A et al. (2003) Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 58, 348-351.
84. Huerta-Yepez S., Baay-Guzman GJ, Bebenek I.G., Hernandez-Pando R, Vega MI, Chi L, Riedl M., DiazSanchez D, Kleerup E, Tashkin DP et al. (2011) Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy 66, 909-918.
85. Capece D, Fischietti M, Verzella D., Gaggiano A, Cicciarelli G, Tessitore A., Zazzeroni F & Alesse E (2013) The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumorassociated macrophages. BioMed Res Int 2013, 187-204.
86. Pikarsky E, Porat RM, Stein I, Abramovitch R., Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E & Ben-Neriah Y (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466.
87. Saccani A, Schioppa T, Porta C., Biswas SK, Nebuloni M, Vago L, Bottazzi B., Colombo MP, Mantovani A & Sica A (2006) p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 66, 11432-11440.
88. Doedens AL, Stockmann C, Rubinstein M.P., Liao D., Zhang N, DeNardo DG, Coussens L.M., Karin M., Goldrath AW & Johnson RS (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70, 7465-7475.
89. Scholz CC & Taylor CT (2013) Targeting the HIF pathway in inflammation and immunity. Curr Opin Pharmacol 13, 646-653.
90. Tambuwala MM, Manresa MC, Cummins E.P., Aversa V., Coulter IS & Taylor CT (2015) Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis. J Control Release 217, 221-227.